RT Journal Article
SR Electronic
T1 Educational Inequality in Multimorbidity: Causality and Causal Pathways. A Mendelian Randomisation Study in UK Biobank
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.14.22276388
DO 10.1101/2022.06.14.22276388
A1 North, Teri-Louise
A1 Harrison, Sean
A1 Bishop, Deborah C
A1 Wootton, Robyn
A1 Carter, Alice R
A1 Richardson, Tom G
A1 Payne, Rupert A
A1 Salisbury, Chris
A1 Howe, Laura D
YR 2022
UL http://medrxiv.org/content/early/2022/06/16/2022.06.14.22276388.abstract
AB Objectives Multimorbidity, typically defined as having two or more long-term health conditions, is a common patient characteristic that is associated with reduced wellbeing and life expectancy. Understanding the determinants of multimorbidity may help with the design and prioritisation of interventions to prevent multimorbidity. This study examined potential causal determinants (education, BMI, smoking and alcohol consumption) of multimorbidity, and assessed the extent to which BMI, smoking and alcohol consumption explain observed educational inequalities in multimorbidity.Design Mendelian randomization study; an approach that uses genetic variants as instrumental variables to interrogate causality.Participants 181,214 females and 155,677 males, mean ages 56.7 and 57.1 years respectively, from UK Biobank.Main outcome measures Multimorbidity status (2+ self-reported health conditions); secondary analyses considered complex multimorbidity defined as 3+ or 4+ conditions, and a continuous multimorbidity score.Results Mendelian randomization suggests that lower education, higher BMI and higher levels of smoking causally increase the risk of multimorbidity. For example, one standard deviation (equivalent to 5.1 years) increase in years of education decreases the risk of multimorbidity by 9.0% (95% CI: 6.5 to 11.4%). A 5 kg/m2 increase in BMI is associated with a 9.2% increased risk of multimorbidity (95% CI: 8.1 to 10.3%) and a one SD higher lifetime smoking index is associated with a 6.8% increased risk of multimorbidity (95% CI: 3.3 to 10.4%). Evidence for a causal effect of alcohol consumption on multimorbidity was less strong; an increase of 5 units of alcohol per week increases the risk of multimorbidity (2+ conditions) by 1.3% (95% CI: 0.2 to 2.5%). The proportions of the association between education and multimorbidity explained by BMI and smoking are 20.4% and 17.6% respectively. Collectively, BMI and smoking account for 31.8% of the educational inequality in multimorbidity.Conclusions Education, BMI, smoking and alcohol consumption are intervenable risk factors that our results suggest have a causal effect on multimorbidity. Furthermore, BMI and lifetime smoking make a considerable contribution to the generation of educational inequalities in multimorbidity. Public health interventions that improve population-wide levels of these risk factors are likely to reduce multimorbidity and inequalities in its occurrence.SECTION 1: WHAT IS ALREADY KNOWN ON THIS TOPIC- Multimorbidity has several known lifestyle and anthropometric risk factors and is associated with deprivation.- The effect of education (proxying deprivation) on multimorbidity is likely mediated by some of these intervenable risk factors.- These associations are likely to be confounded and their causality is not well understood.SECTION 2: WHAT THIS STUDY ADDS- Analyses using genetically predicted effects suggest that education, BMI, smoking and alcohol consumption each have a causal effect on multimorbidity and that 32% of the educational inequality in multimorbidity is attributable to BMI and smoking combined.Competing Interest StatementTGR is employed part-time by Novo Nordisk outside of this work.Funding StatementLDH and TLN are supported by a Career Development Award from the UK Medical Research Council, to LDH (MR/M020894/1). ARC is supported by the MRC Integrative Epidemiology Unit (MC_UU_00011/6) and the University of Bristol British Heart Foundation Accelerator Award (AA/18/7/34219). CS is partially supported by NIHR ARC West and is an NIHR Senior Investigator. DCB is supported by Wellcome and is a PhD student. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:North West Multi-centre Research Ethics Committee of the UK Research Ethics Committees gave ethical approval for UK Biobank (REC reference 11/NW/0382)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available on request from UK Biobank. Statistical code are currently available on request; they will shortly be published on a code repository https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access